Physician profile
Tracy M Hitzeman
NPI 1740695733
$5,690.13
in general payments reported to CMS, 2019-2025
37 companies · $1,581 in 2025
The $1,581 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $738 · 2020: $199 · 2021: $293 · 2022: $539 · 2023: $927 · 2024: $1,413 · 2025: $1,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,922.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,274.55 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $880.76 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $574.69 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $340.70 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $302.35 | 2019-2025 | |
| Amgen INC. | $293.79 | 2019-2025 | Repatha, Repatha, Otezla |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $189.51 | 2024-2025 | Caplyta |
| Axsome Therapeutics, INC. | $179.27 | 2023-2025 | Auvelity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.94 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $156.07 | 2019-2020 | |
| Exact Sciences Corporation | $122.18 | 2023-2025 | Cologuard Collection Kit |
| Lundbeck LLC | $121.57 | 2024-2025 | Rexulti, Vyepti |
| Allergan, INC. | $112.40 | 2019 | |
| Glaxosmithkline, LLC. | $97.19 | 2019-2025 | Trelegy Ellipta |
| Alnylam Pharmaceuticals INC. | $90.47 | 2023-2024 | Onpattro |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Hitzeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.